From a9622155f9f91d4bac5e30ee2ca20b682c76c39a Mon Sep 17 00:00:00 2001 From: HM Rando Date: Mon, 13 Sep 2021 18:08:43 -0400 Subject: [PATCH] remove ebm-trials fig --- content/60.methods.md | 9 --------- 1 file changed, 9 deletions(-) diff --git a/content/60.methods.md b/content/60.methods.md index 2054c338d..45553c005 100644 --- a/content/60.methods.md +++ b/content/60.methods.md @@ -214,14 +214,6 @@ Additionally, the framework for evaluating literature was converted into issue t Articles were classified as _diagnostic_, _therapeutic_, or _other_, with an associated template developed to guide the review of papers and preprints in each category. A total of 273 new paper issues had been opened as of April 30, 2021. -![ -**Change in the COVID-19 clinical trials figure over time.** -When we first produced this figure on July 7, 2020, there were 3,733 clinical trials in the University of Oxford Evidence-Based Medicine Data Lab's COVID-19 TrialsTracker [@doi:10.5281/zenodo.3732709]. -As of {{ebm_date_pretty}}, it contains {{ebm_all_trials}}. -We were also able to easily reconfigure the figure prior to journal submission to emphasize interventional trials based on the recommendation of a collaborator who is a clinician. -This figure is included in an analysis of pharmaceutical development efforts during COVID-19 [@individual-pharmaceuticals]. -]((images/ebmdatalab-trials-original.png){{ebm_trials_figure}} "COVID-19 clinical trials"){#fig:ebm-trials secno=1} - The seven manuscripts produced by the consortium (outside of this one) will be submitted to _mSystems_ as part of a special issue that is providing support for evolving reviews so that they can continue to be updated as more information becomes available. This approach allows for a version of record to be maintained alongside the most recent developments, which are always available through GitHub. The first of these manuscripts was recently published [@individual-nutraceuticals]. @@ -239,7 +231,6 @@ Thus, the consortium was successful in providing a venue for researchers across We integrated data into the manuscripts from several sources. Data about worldwide cases and deaths came from the COVID-19 Data Repository by the Center for Systems Science and Engineering at Johns Hopkins University^[https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series]. Similarly, the clinical trials statistics and figure were generated based on data from the University of Oxford Evidence-Based Medicine Data Lab's COVID-19 TrialsTracker [@doi:10.5281/zenodo.3732709]. -The evolution of this figure over time is shown in Figure @fig:ebm-trials. Information about vaccine distribution was extracted from Our World In Data^[https://github.com/owid/covid-19-data] [@owidcoronavirus]. Figure 1 dynamically integrates data directly from the CORD-19 dataset [@arxiv:2004.10706].